Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 – 2016)

Table 1 Reported outcomes and their follow up periods

Study	Reported outcomes	Follow up periods	Type of follow up
Bhurke 2012 [17]	MI and revascularization	9 months	Short term
Burkard 2012 [18]	Death, MI, ST, MACE, TVR	3 years	Long term
Chitose 2012 [19]	Death, MI	18 months	Long term
Douglas 2012 [20]	Death, MI	10 months	Short term
Dunn 2013 [21]	Death, MI, TVR	1 month	Short term
Goodman 2012 [22]	Death, MI, ST	1 year	Long term
Hsieh 2015 [23]	MI, revascularization	1 year	Long term
Macaione 2012 [24]	Death, MI, TVR	3 years	Long term
Weisz 2015 [25]	Death, MACEs, MI, ST, TVR	In hospital, 2 years	Short and long term
Zou 2014 [26]	Death, MACEs, MI, ST, TVR	1 year	Long term
Gargiolo 2016 [16]	Death, MACEs, MI, ST	2 years	Long term

Abbreviations: MI Myocardial infarction, ST Stent thrombosis, MACEs Major adverse cardiac events, TVR Target vessel revascularization

ISSN: 1471-2261